IN2013MU00665A - - Google Patents

Download PDF

Info

Publication number
IN2013MU00665A
IN2013MU00665A IN665MU2013A IN2013MU00665A IN 2013MU00665 A IN2013MU00665 A IN 2013MU00665A IN 665MU2013 A IN665MU2013 A IN 665MU2013A IN 2013MU00665 A IN2013MU00665 A IN 2013MU00665A
Authority
IN
India
Prior art keywords
present
novel compounds
provides
oxalate
raloxifene
Prior art date
Application number
Other languages
English (en)
Inventor
Srinivas Laxminarayan Pathi
Dharmaraj Ramachandra Rao
Rajendra Narayanrao Kankan
Chandrasekaran Ramasubbu
Original Assignee
Cipla Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cipla Ltd filed Critical Cipla Ltd
Priority to IN665MU2013 priority Critical patent/IN2013MU00665A/en
Priority to ZA2014/01636A priority patent/ZA201401636B/en
Priority to PCT/GB2014/000081 priority patent/WO2014135834A1/en
Publication of IN2013MU00665A publication Critical patent/IN2013MU00665A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/56—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN665MU2013 2013-03-05 2014-03-05 IN2013MU00665A (ru)

Priority Applications (3)

Application Number Priority Date Filing Date Title
IN665MU2013 IN2013MU00665A (ru) 2013-03-05 2014-03-05
ZA2014/01636A ZA201401636B (en) 2013-03-05 2014-03-05 Oxalic acid addition salts and/or solvates of a selective estrogen receptor modulator
PCT/GB2014/000081 WO2014135834A1 (en) 2013-03-05 2014-03-05 Oxalic acid addition salts and/or solvates of a selective estrogen receptor modulator

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN665MU2013 IN2013MU00665A (ru) 2013-03-05 2014-03-05

Publications (1)

Publication Number Publication Date
IN2013MU00665A true IN2013MU00665A (ru) 2015-07-03

Family

ID=50382470

Family Applications (1)

Application Number Title Priority Date Filing Date
IN665MU2013 IN2013MU00665A (ru) 2013-03-05 2014-03-05

Country Status (3)

Country Link
IN (1) IN2013MU00665A (ru)
WO (1) WO2014135834A1 (ru)
ZA (1) ZA201401636B (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3312184A4 (en) 2015-06-16 2019-02-27 Jiangsu Hengrui Medicine Co., Ltd. PIPERIDINE DERIVATIVE AND ITS PREPARATION METHOD AND PHARMACEUTICAL USE THEREOF
WO2017107754A1 (zh) 2015-12-22 2017-06-29 江苏恒瑞医药股份有限公司 苯并哌啶类衍生物、其制备方法及其在医药上的应用
KR20220125272A (ko) 2020-01-10 2022-09-14 지앙수 헨그루이 파마슈티컬스 컴퍼니 리미티드 트리사이클릭 테트라하이드로이소퀴놀린 유도체, 이를 제조하기 위한 방법 및 의료분야에서 이의 용도
AU2022307207A1 (en) 2021-07-09 2024-02-15 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Salt types of tricyclic tetrahydro isoquinoline derivative

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4133814A (en) 1975-10-28 1979-01-09 Eli Lilly And Company 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
US4380635A (en) 1981-04-03 1983-04-19 Eli Lilly And Company Synthesis of acylated benzothiophenes
US4358593A (en) 1981-04-03 1982-11-09 Eli Lilly And Company Process for preparing 3-(4-aminoethoxybenzoyl)benzo[b]thiophenes
TW366342B (en) 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
CO4410191A1 (es) 1994-09-19 1997-01-09 Lilly Co Eli SINTESIS DE 3-[4-(2-AMINOETOXI)BENZOIL]-2-ARIL-6- HIDROXIBENZO [b] TIOFENOS
US5629425A (en) * 1994-09-19 1997-05-13 Eli Lilly And Company Haloalkyl hemisolvates of 6-hydroxy-2-(4-hydroxyphenyl)-3-[4-piperidinoethoxy)-benzoyl]benzo[b]thiophene
JP2001523252A (ja) 1997-04-30 2001-11-20 イーライ・リリー・アンド・カンパニー 置換ベンゾ［ｂ］チオフェンの位置選択的アルキル化製造法
EP1832583A1 (en) 2002-09-30 2007-09-12 A/S GEA Farmaceutisk Fabrik Novel raloxifene sulphuric acid addition salts and/or solvates thereof, and pharmaceutical compositions comprising these
EP2436381A1 (en) * 2006-06-27 2012-04-04 Sandoz AG Crystallization of hydrohalides of pharmaceutical compounds
GB2456096B (en) * 2006-10-17 2011-08-17 Cipla Ltd Crystalline form of benzothiophene compound and process for preparation thereof
WO2011099942A1 (en) 2010-02-09 2011-08-18 Silverstone Pharma New addition salts of raloxifene, process for the preparation thereof and use thereof in therapy

Also Published As

Publication number Publication date
ZA201401636B (en) 2014-11-26
WO2014135834A1 (en) 2014-09-12
WO2014135834A8 (en) 2014-11-27

Similar Documents

Publication Publication Date Title
PH12018500591A1 (en) Heterocyclic compounds and uses thereof
TW201613911A (en) Heterocyclic compounds and uses thereof
PH12016501192B1 (en) Tetrahydropyridopyrazines modulators of gpr6
MX2017004200A (es) Compuestos de heteroarilo como inhibidores de tirosina-cinasa de bruton (btk) y usos de estos.
PH12015501996B1 (en) Heterocyclic compounds and uses thereof
MX2016013689A (es) Compuestos 4-amino-imidazoquinolina.
CL2015002628A1 (es) Compuestos de heteroarilo y sus usos.
PH12017500660A1 (en) Novel compositions, uses and methods for making them
MX2016015565A (es) Ciertos inhibidores de la proteina quinasa.
MX2017008518A (es) Compuestos de isoquinolina para el tratamiento de virus de inmunodeficiencia humana (vih).
PH12015501609A1 (en) Phenicol antibacterials
PH12017501539A1 (en) Disacetoxytubulysin h and analogs thereof
MX2018012085A (es) Compuestos agonistas de gpr119 y metodo para tratar enfermedades y afecciones mediado a traves de gpr119.
TW201613864A (en) Novel compounds
PH12018500504A1 (en) Compounds useful for inhibiting ror-gamma-t
IN2013MU03862A (ru)
IN2013MU00665A (ru)
IN2015DN02109A (ru)
HK1225381A1 (zh) 具抗記憶錯誤效果的乙酰膽碱酯酶抑制劑和5-羥色胺受體4(5ht4)激動劑的化合物，其製備方法及其含有的藥物組合物
MX2015014657A (es) Nuevos agentes antibacterianos de fenicol.
PH12017501147A1 (en) Total synthesis of trioxacarcin dc-45-a2 and preparation of trioxacarcin analogs
IN2013MU02010A (ru)
MX2017005669A (es) Derivados de hidroxido de bencilo, preparacion de los mismos y uso terapeutico de los mismos.
IN2013MU01524A (ru)